ACADEMIC RESEARCH

  

Introductory Pricing for Academic Research

Stephen B. Squires, Founder and CEO of Quantum Materials Corporation said:

“We believe that our tetrapod quantum dots are truly an enabling technological breakthrough. As such we have an obligation to make sure these materials are accessible to researchers across the globe so discovery in the advanced electronics and life sciences fields, among others, can be realized and accelerated. Offering QMC tetrapod quantum dots at a substantial cost savings will increase access to experimentation as the range of quantum dot research also widens. There are a number of potential applications for quantum dots that have not been well described and we really believe this is going to be the kind of platform technology that spurs innovation and creativity throughout the scientific community.”

Due to lowered component cost and manufacturing advantages, QMC has initiated sales operations by marketing its high purity, uniform tetrapod quantum dot production at low introductory pricing to the life sciences, academic, and other industrial research and development (R&D) communities. “Research” pricing to the academic community and potential partners will spur development of new market opportunities. The unique properties and quantum effects of quantum dots will cause advances in diverse fields including biology and biomedicine; computing and memory; electronics and displays; optoelectronic devices such as solar cells, LEDs, lighting, and lasers; optical components used in telecommunications; and security applications such as covert identification tagging or biowarfare detection sensors.

We expect to see a strong demand for this product from Universities and R&D arms of nanotech manufacturers of electric light bulbs, electronic equipment, particularly screens for computers, TV, advertising displays as well as a variety of medical uses. Using quantum dots, screens for computers, televisions, advertising displays, cell phones and other electronic devices can produce clearer, sharper pictures at less cost. In addition, there are medical uses, such as biomarkers, which have tremendous potential in deepening the understanding of diseases including cancer and innovating new and dramatically better treatments.

Global QD Market Projections

According to a report by BCC Research, the global market for QDs, which in 2008 was estimated to generate $28.6 million in revenues, is projected to grow over the next 5 years at a compound annual growth rate (CAGR) of 90.7%, reaching over $700 million by 2013. Following the initially modest revenues generated by standalone colloidal QDs - primarily serving the life sciences, academic, and other industrial research and development (R&D) communities - within the next 2 years several product launches with colloidal or in situ QD underpinning will bolster market revenue considerably.